Clinical Trials Browser

Phase 3 × Muscle Weakness × Clear all

NCT05737160 2025-05-23

Study of Telitacicept in Generalized Myasthenia Gravis

Phase 3 Completed

Autoimmune Diseases, Myasthenia Gravis, Muscle Weakness